TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Microbot Medical ( (MBOT) ).
On September 29, 2025, Microbot Medical Inc. announced that a holder exercised 600,000 series H preferred investment options for common stock, receiving new series J options as part of a previously-disclosed inducement agreement. Additionally, the company issued 30,000 preferred investment options to H.C. Wainwright & Co., LLC, with the remaining options expected to be exercised by October 15, 2025. Earlier, on September 23, 2025, Microbot Medical issued 374,167 shares of common stock from the exercise of preferred investment options, generating approximately $896,000 in gross proceeds.
The most recent analyst rating on (MBOT) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.
More about Microbot Medical
Microbot Medical Inc. is a company operating in the medical industry, focusing on developing innovative robotic medical technologies and devices.
Average Trading Volume: 4,099,960
Technical Sentiment Signal: Buy
Current Market Cap: $144.4M
For detailed information about MBOT stock, go to TipRanks’ Stock Analysis page.